These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19367650)

  • 21. Rebound increase in migraines following PFO closure.
    Bhindi R; Ormerod OJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):719; author reply 720. PubMed ID: 18360874
    [No Abstract]   [Full Text] [Related]  

  • 22. Malpositioned PFO device repair after the fact. Percutaneously? Really?
    Butman SM
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):782-3. PubMed ID: 20333774
    [No Abstract]   [Full Text] [Related]  

  • 23. Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients.
    Sievert H; Ruygrok P; Salkeld M; Baumgartner H; Meier B; Windecker S; Juliard JM; Aubry P; Tiefenbacher C; Krumsdorf U; Vermeersch P; Ewert P; Piéchaud JF
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):368-73. PubMed ID: 19133667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PFO closure devices: The disconnect between technology, technique, and indications for use.
    Feldman T
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):403-4. PubMed ID: 18288746
    [No Abstract]   [Full Text] [Related]  

  • 25. Pediatric interventional cardiology in the United States is dependent on the off-label use of medical devices.
    Sutherell JS; Hirsch R; Beekman RH
    Congenit Heart Dis; 2010; 5(1):2-7. PubMed ID: 20136851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
    Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
    Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
    Watson KT; Barash PG
    Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    Circulation; 2009 May; 119(20):2743-7. PubMed ID: 19433754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    J Am Coll Cardiol; 2009 May; 53(21):2014-8. PubMed ID: 19460622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PFO closure in 2008: See through a glass, darkly.
    Carroll JD
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):388-9. PubMed ID: 18288736
    [No Abstract]   [Full Text] [Related]  

  • 31. Patent foramen ovale closure devices: moving beyond equipoise.
    Maisel WH; Laskey WK
    JAMA; 2005 Jul; 294(3):366-9. PubMed ID: 16030282
    [No Abstract]   [Full Text] [Related]  

  • 32. A new form of vascular congestion: Crowded right atrium during new device procedures.
    Feldman T
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):100-1. PubMed ID: 18561160
    [No Abstract]   [Full Text] [Related]  

  • 33. Beyond indications: postmarket surveillance and the importance of expanded and off-label use of transcatheter devices in structural and congenital interventions.
    McElhinney DB
    Circ Cardiovasc Interv; 2012 Dec; 5(6):739-40. PubMed ID: 23250968
    [No Abstract]   [Full Text] [Related]  

  • 34. Burn it, stitch it, plug it...there are many ways to close a PFO: insights into the challenges of medical device development.
    Kaplan AV
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):374-5. PubMed ID: 19213091
    [No Abstract]   [Full Text] [Related]  

  • 35. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
    Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Old customs, ancient lore: the development of custom device law through neglect.
    Klepinski RJ
    Food Drug Law J; 2006; 61(2):237-49. PubMed ID: 16903030
    [No Abstract]   [Full Text] [Related]  

  • 37. Closing a door.
    Butman S
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):396-7. PubMed ID: 18288738
    [No Abstract]   [Full Text] [Related]  

  • 38. Reuser friendly: a review of the regulation of and the product liability regarding the reuse of single-use medical devices.
    Wood JM; Heyman GF
    Tort Insur Law J; 2001; 37(1):41-78. PubMed ID: 11963939
    [No Abstract]   [Full Text] [Related]  

  • 39. Patent foramen ovale closure devices: thoughts from the circulatory device advisory panel.
    Somberg J
    Am J Cardiol; 2007 Sep; 100(5):905-6. PubMed ID: 17719343
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter regarding article by Hara et al, "Patent foramen ovale closure by radiofrequency thermal coaptation: first experience in the porcine model and healing mechanisms over time".
    Stöllberger C; Schneider B; Finsterer J
    Circulation; 2008 Mar; 117(9):e176; author reply e177. PubMed ID: 18316494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.